论文部分内容阅读
目的:分析胰岛素联合口服降糖药物在老年2型糖尿病治疗中应用的可行性。方法:随机将我院诊治的65例患者按照自愿分为对照组和观察组,给予对照组患者主要甘精胰岛素联合格列美脲治疗,给予观察组患者主要采用甘精胰岛素联合阿卡波糖治疗,并观察两组患者治疗效果。结果:治疗前,对两组患者的空腹血糖(FPG)、糖化血红蛋白(Hblc)以及餐后2h血糖(2hPG)水平进行比较,差异均无统计学意义(均P>0.05);治疗后发现,两组的FPG、Hblc、2hPG水平较之治疗前均出现了显著的下降(均P<0.05);且观察组的下降程度较之对照组更加显著(均P<0.05),两组比较差异有统计学意义。结论:甘精胰岛素联合阿卡波糖治疗老年2型糖尿病效果较为显著,值得临床推广。
Objective: To analyze the feasibility of insulin combined with oral hypoglycemic agents in the treatment of type 2 diabetes in the elderly. Methods: Sixty-five patients diagnosed and treated in our hospital were randomly divided into control group and observation group. Patients in control group were treated with glargine and glimepiride. Patients in observation group were treated with insulin glargine and acarbose Treatment, and observe the treatment effect of two groups of patients. Results: Before treatment, there was no significant difference in FPG, Hblc and 2hPG between the two groups (all P> 0.05) The levels of FPG, Hblc and 2hPG in both groups were significantly lower than those before treatment (all P <0.05), and the decrease in the observation group was more significant than that in the control group (all P <0.05) Statistical significance. Conclusion: Glargine and acarbose treatment of elderly type 2 diabetes more effective, worthy of clinical promotion.